Literature DB >> 11559803

Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism.

E S Lee1, H Zhou, A J Henderson.   

Abstract

Macrophages are early targets of human immunodeficiency virus type 1 (HIV-1) infection and serve as potential reservoirs for long-term infection. Through inflammatory mediators and direct cell contact, infected macrophages interact with neighboring cell populations, such as the endothelium, which create a microenvironment favorable for HIV-1 replication. We hypothesize that the transcriptional activator C/EBPbeta is critical for macrophages to respond to endothelial cell-derived signals. We show that endothelial cells significantly enhance C/EBPbeta binding activity and HIV-1 replication in macrophages. This increase in HIV-1 transcription is due to cell-cell contact as well as the production of soluble factors, mediated in part by ICAM-1 and interleukin 6, respectively. Furthermore, C/EBP factors are necessary for endothelial cell-dependent activation of HIV-1 transcription in macrophages, and HIV-1 induction can be inhibited by a C/EBP dominant-negative protein. In addition, C/EBP binding sites are necessary for efficient LTR activity and HIV-1 replication in the presence of endothelial cells. Taken together, these results indicate that endothelial cells, through the activation of C/EBPbeta, provide a microenvironment that supports HIV-1 replication in monocytes/macrophages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559803      PMCID: PMC114542          DOI: 10.1128/JVI.75.20.9703-9712.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.

Authors:  M R Ruocco; X Chen; C Ambrosino; E Dragonetti; W Liu; M Mallardo; G De Falco; C Palmieri; G Franzoso; I Quinto; S Venuta; G Scala
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

2.  C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines.

Authors:  A J Henderson; R I Connor; K L Calame
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

3.  CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.

Authors:  A J Henderson; K L Calame
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Authors:  J M Jacqué; B Fernández; F Arenzana-Seisdedos; D Thomas; F Baleux; J L Virelizier; F Bachelerie
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.

Authors:  A J Henderson; X Zou; K L Calame
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.

Authors:  S R Bartz; M A Vodicka
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

7.  Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.

Authors:  F Samaniego; P D Markham; R Gendelman; R C Gallo; B Ensoli
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

8.  Cell-to-cell contact activates the long terminal repeat of human immunodeficiency virus 1 through its kappaB motif.

Authors:  E Faure; P Lecine; C Lipcey; S Champion; J Imbert
Journal:  Eur J Biochem       Date:  1997-03-01

Review 9.  Transcriptional regulation of the human intercellular adhesion molecule-1 gene: a short overview.

Authors:  C Stratowa; M Audette
Journal:  Immunobiology       Date:  1995-07       Impact factor: 3.144

10.  Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact.

Authors:  P N Gilles; J L Lathey; S A Spector
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  7 in total

1.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Function of small hydrophobic proteins of paramyxovirus.

Authors:  Rebecca L Wilson; Sandra M Fuentes; Ping Wang; Erica C Taddeo; Alicia Klatt; Andrew J Henderson; Biao He
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

Authors:  S Mark Tompkins; Yuan Lin; George P Leser; Kari A Kramer; Debra L Haas; Elizabeth W Howerth; Jie Xu; Mary J Kennett; Russell K Durbin; Joan E Durbin; Ralph Tripp; Robert A Lamb; Biao He
Journal:  Virology       Date:  2007-01-23       Impact factor: 3.616

4.  Induction of interleukins IL-6 and IL-8 by siRNA.

Authors:  E Pauls; J Senserrich; M Bofill; B Clotet; J A Esté
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

5.  Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene.

Authors:  Yuan Lin; Angela C Bright; Terri A Rothermel; Biao He
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 6.  HIV UTR, LTR, and Epigenetic Immunity.

Authors:  Jielin Zhang; Clyde Crumpacker
Journal:  Viruses       Date:  2022-05-18       Impact factor: 5.818

Review 7.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.